| Value | ₹0.01 Cr |
|---|---|
| Execution period | Vesting over 3-4 years |
BSE filing, NSE: DELHIVERY. Summary written from the filing by ALFA Finder's alert engine.
Delhivery Ltd: key numbers
- Share price
- ₹385.00
- Market cap
- ₹28,857 Cr
- Revenue (annual)
- ₹10,508 Cr
- Net profit (annual)
- ₹152.7 Cr
- P/E (TTM)
- 308.5×Sector 29.6×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 39.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Delhivery Ltd
All →Delhivery Board Meeting Date
Delhivery Limited will hold a board meeting on October 30, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Delhivery Other Announcement
Delhivery Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Delhivery Business Update
Delhivery won the Golden Peacock Award for Excellence in Corporate Governance 2026 in the Logistics sector. The recognition was awarded by the Institute of Directors, India.
Delhivery Employee Stock Options
Delhivery Ltd allotted 2,28,116 equity shares upon the exercise of vested stock options under its ESOP plans. The allotment increases the company's paid-up share capital.
- Value
- ₹0.07 Cr
Delhivery Employee Stock Options
Delhivery Ltd has granted 52,600 stock options to eligible employees under its ESOP 2012 plan. This action is part of the company's ongoing employee incentive scheme.
Delhivery Employee Stock Options
Delhivery Limited has granted 9,00,000 stock options under its ESOP-2021 plan. The options are exercisable at Re. 1 per share subject to vesting conditions.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.